Total Pageviews

Friday, December 16, 2011

Why Does the Same Mutation Kill One Person but Not Another?

ScienceDaily (Dec. 7, 2011) — The vast majority of genetic disorders (schizophrenia or breast cancer, for example) have different effects in different people. Moreover, an individual carrying certain mutations can develop a disease, whereas another one with the same mutations may not. This holds true even when comparing two identical twins who have identical genomes. But why does the same mutation have different effects in different individuals?
The figure shows how the same mutation can differently affect each individual from C. elegans. The dice represent the stochastic component in the gene expression. (Credit: Image courtesy of Centre for Genomic Regulation)
Since the early twentieth century researchers have studied the role that genetic variability (mutations) and the environment (consumption habits, lifestyle, etc.) have in the development of diseases. "However, genetic and environmental differences are not enough" said Alejandro Burga, one of the authors of the article. "In the last decade we have learned by studying very simple organisms such as bacteria that gene expression -- the extent to which a gene is turned on or off -- varies greatly among individuals, even in the absence of genetic and environmental variation. Two cells are not completely identical and sometimes these differences have their origin in random or stochastic processes. The results of our study show that this type of variation can be an important influence the phenotype of animals, and that its measurement can help to reliably predict the chance of developing an abnormal phenotype such as a disease ."
The researchers conducted their study using the roundworm Caenorhabditis elegans as a model. Due to its simplicity, this microscopic worm is one of the most widely studied organisms in biology, and was the first animal to have its genome sequenced. Recently three different Nobel Prizes have been awarded for research using C. elegans.
Since the genetic composition and the environment are insufficient to determine whether or not a mutation will affect an individual, they developed a methodology to measure small differences in gene expression in vivo. "The challenge was not only to develop a method to quantify these small differences among individuals, but also to predict which genes are relevant for a particular mutation," adds Ben Lehner, coordinator of the study and ICREA Research Professor in the European Molecular Biology Laboratory-Centre for Genomic Regulation Systems Biology Research Unit. "In both round worms and humans, genes cooperate and help each other to perform functions within the cell. A few genes are very "generous" and help hundreds of others to perform many different processes, whereas others only help a few other genes to perform more specific functions. The key to predict what will happen in each individual is to measure variation in the expression of both types of gene."
The work suggests that, even if we completely understand all of the genes important for a particular human disease, we may never be able to predict what will happen to each person from their genome sequence alone. Rather, to develop personalised and predictive medicine it will also be necessary to consider the varying extent to which genes are turned on or off in each person.
The study was funded by the European Research Council, the Institució Catalana de recerca i Estudis Avanzats (ICREA) and the Ministry of Science and Innovation (MICINN).

Thursday, December 15, 2011

Happy holidays and advance new year wishes

Dear Staff and Students,
Semester holidays are announced from 21/12/11 to 03/01/13. Enjoy your free days and rejuvenate yourself, because we will be having lot of activities in coming months. 17/12/11 will be a working day.

Regards.
Ramesh.B

Lessons Learned from Yeast About Human Leukemia: The Power of Basic Model Organisms in Human Health

ScienceDaily (Dec. 5, 2011) — The trifecta of biological proof is to take a discovery made in a simple model organism like baker's yeast and track down its analogs or homologs in "higher" creatures right up the complexity scale to people, in this case, from yeast to fruit flies to humans. In a pair of related studies, scientists at the Stowers Institute for Medical Research have hit such a trifecta, closing a circle of inquiry that they opened over a decade ago.


Stowers investigator, Ali Shilatifard, Ph.D., and his team finally confirmed that the molecular mechanics of a key regulatory complex implicated in human leukemia, which Shilatifard had first identified in yeast, are the same on each rung of the evolutionary ladder, all the way from yeast to fruit flies to humans. In addition, the Stowers team, working closely with collaborators at the University of Michigan, revealed the common molecular shape at the center of the complex, which regulates gene expression through the methylation of histone H3, one of several DNA packaging proteins.
These findings are important, says Shilatifard, for understanding a fundamental developmental process -- histone methylation. Understanding this protein modification, which protects, packages, and controls the output of expression from DNA, is essential for finding new ways to treat leukemia arising as a result of chromosomal translocations.
About 30 years ago, Janet Rowley, a physician and geneticist, was the first to propose that translocation, the swapping of chromosomal sections into abnormal locations during replication, was a cause of aggressive leukemia. Considered heresy at the time, Rowley's theory was briskly dismissed, but gained adherents as evidence piled up that the translocation of one gene in particular was a marker for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). This most commonly translocated gene became known as MLL or the "mixed-lineage leukemia" gene, and it is widely used today for diagnostics and determining therapy in patients.
Determined to explain just how the misplaced MLL causes leukemia, Shilatifard purified one of the first known interaction partners of human MLL about 16 years ago. Surprisingly, the protein functioned in transcription elongation, a key step in the process that leads to gene expression. Unable to make further progress on MLL in mouse models, he turned to a possible MLL homolog, a gene called Set1, in the humble baker's yeast.
"About 12 years ago, we decided to use yeast, Saccharomyces cerevisiae, as a model system to learn about human leukemia," Shilatifard recalls. "Everyone thought we were out of our minds." Undaunted, the Shilatifard lab extracted Set1 protein from 300 liters of S. cerevisiae culture and found that Set1 belongs to a complex they dubbed COMPASS (Complex of Proteins Associated with Set1). In a major find, they had identified the first H3K4 (histone 3, lysine 4) methylase complex, an enzyme that modifies histones. Histones are protein spools around which long DNA helices are wound inside the cell nucleus. Methylation or demethylation (addition or removal of individual methyl groups) tightens or loosens histone spools, turning genes off or on.
More than a decade later, a study led by postdoctoral fellow Man Mohan, Ph.D., which was featured on the cover of the Nov. 1, 2011, issue of Molecular and Cellular Biology, firmly connects the yeast complex, known as Set1/COMPASS, to its fruit fly homologs, three COMPASS-like complexes built around the Drosophila melanogaster gene, Trithorax (Trx).
The second study, published in the online Early Edition of the Proceedings of the National Academy of Science the week of Dec. 5, 2011, features the work of postdoctoral fellow Yoh-hei Takahasi, Ph.D., who painstakingly reconstituted the Set1/COMPASS from its component molecules both in yeast and human cells.
Working with Gerwin Westfield in the lab of structural biologist Georgios Skiniotis at the University of Michigan, they used state-of-the-art electron microscopy techniques to map out the Y-shaped molecular structure at the heart of the complex. "It was a very challenging project, but I am so glad to see Ali's many years of effort come to fruition and my lab being part of this breakthrough," says Skiniotis.
The mechanisms of histone methylation such as the Set1/COMPASS complex are conserved by evolutionary selection across a wide range of eukaryote organisms, which is why Shilatifard was able to move from the Set1/COMPASS in yeast to three COMPASS-like complexes involving trithorax in Drosophila, to six COMPASS-like complexes in MLL in humans. These factors are now known as the COMPASS family.
"Given the conservation of COMPASS family from yeast to human, having the 3D structure of the core complex not only reveals the fundamental architectural blueprint, but provides molecular insights into the function of the H3K4 methylase complexes," says Shilatifard. "And guess what?" says Shilatifard. "Comparing the overall architectures we cannot tell the difference between the yeast enyme and the human enzyme. They look almost identical!"
It's been a long but satisfying scientific journey to bring the Set1/COMPASS story together, says Shilatifard. "So the lesson learned is that yeast is an excellent model for studying the molecular basis of human leukemia."
Researchers who also contributed to the study published in PNAS include Austin Oleskie at the Life Sciences Institute at the University of Michigan in Ann Arbor and Raymond Trievel in the Department of Biological Chemistry at the University of Michigan Medical School in Ann Arbor. Researchers who also contributed to the study published in MCB include Hans Martin Herz, Edwin R. Smith, Ying Zhang, Michael P. Washburn and Laurence Florens at the Stowers Institute for Medical Research as well as Jessica Jackson and Joel C. Eissenberg in the Edward A. Doisy Department of Biochemistry and Molecular Biology at the Saint Louis University School of Medicine.

Workshop for Teaching Faculties of Life Sciences on ‘Quantification of Biomolecules’


Hearty congratulations for Dr.A.Koodalingam and Mrs.M.Pratheeba for attending Workshop  for Teaching Faculties of Life Sciences on ‘Quantification of Biomolecules’ Organized by Eppendorf India Limited (8.12.2011).


Wednesday, December 14, 2011

A 'Wild Card' in Your Genes

ScienceDaily (Dec. 7, 2011) — The human genome and the endowments of genes in other animals and plants are like a deck of poker cards containing a "wild card" that in a genetic sense introduces an element of variety and surprise that has a key role in life. That's what scientists are describing in a review of more than 100 studies on the topic that appears in ACS Chemical Biology.

Rahul Kohli and colleagues focus on cytosine, one of the four chemical "bases" that comprise the alphabet that the genetic material DNA uses to spell out everything from hair and eye color to risk of certain diseases. But far from just storing information, cytosine has acquired a number of other functions that give it a claim to being the genome's wild card. "In poker, the rules of the game can occasionally change," they note in the article. "Adding a 'wild card' to the mix introduces a new degree of variety and presents opportunities for a skilled player to steal the pot. Given that evolution is governed by the same principles of risk and reward that are common to a poker game, it is perhaps not surprising that a genomic 'wild card' has an integral role in biology."

They discuss the many faces of cytosine that make it such a game-changer and the biological processes that help to change its identity. Removing something called an amine group from cytosine, for instance, allows the immune system to recognize and destroy foreign invaders such as viruses. Adding so-called "methyl groups" on cytosines acts as on/off switches for genes. The authors say that these many faces of cytosine allow it to play various roles and give it true "wild card" status.

Tuesday, December 13, 2011

Educationcal Scholarship Sponsored by MHRD for March 2011


Last date extended up to 30th December. I request all the eligible studetns to apply.
Application can be downloaded from http://tndce.in/NotificationPDF/National%20Merit%20Scholarship.pdf

Friday, December 9, 2011

NATIONAL SEMINAR ON RECENT ADVANCES IN MICROBIAL BIOTECHNOLOGY 06/12/11





























SUBJECT EXPERT COMMITTEE MEETING - PREPARATION OF DICTIONARY OF BIOTECHNOLOGY

Subject expert committee meeting for the preparation of Dictionary of Biotechnology sponsered by Commission for Scientific & Technical Terminology, Ministry of Human Resource Development (MHRD), Govt. of India was held between 05/12/11 - 08/12/11 (4 days). Photographs of committee members with our college principal Prof.K.R.Venkatesan and the meeting are given below;

Ramesh.B

Saturday, December 3, 2011

WALK‐IN‐INTERVIEW

Candidates who possess the qualification mentioned below may attend the WALK‐IN INTERVIEW on 05.12.2011 between 9.00 AM to 12.00 PM with all original certificates, including community certificate and recent passport size photograph. The selected candidates will be working under the DBT project entitled “Characterization of the bacterial toxins isolated from soil samples for the control of mosquito vectors”. The selected candidate will be appointed initially for a period of one year and will be extended upto three years based on their performance and availability of funds.

I. Name of the post : Junior Research Fellow – 1 post
II. Educational qualification : Master’s degree in Zoology/ Microbiology/
Biotechnology/ Life sciences

2. Qualified in the entrance examination conducted
by Pondicherry central University for PhD admission
IV. Nature of Research : To conduct research in the field of characterization of
mosquitocidal toxin from marine bacteria
V. Fellowship : Rs.12,000/‐ + 20% HRA for 1st & 2rd year
and Rs.14,000/‐ + 20% HRA for 3rd year

VI. Duration of the project JRF : 2 years as JRF and 1 year as SRF (subject to
progress based on yearly assessment)

VII. Age limit : Below 28 years and relaxable for SC/ST and OBC candidates, as per Govt. of India rules in force

VIII. Venue : Vector Control Research Centre, Indira Nagar, Pondicherry – 605006
Candidates who wish to appear for the interview can download the application format given in the web site (www. icmr.nic.in) and complete it and bring it along with the required enclosures. Any canvassing by or on behalf of the candidate or bringing political or other outside influence with regard to selection shall be a disqualification and such candidates will not be entertained. No TA/DA will be paid for attending the interview.

Friday, December 2, 2011

JUNIOR RESEARCH FELLOW

Dear students,
Applications are invited for JUNIOR RESEARCH FELLOW in VIT
Sponsoring agency : DBT
Fellowship : 14,000/- pm
Qulification : M.Sc Biotechnology
Last date : 10.12.2011